Dapiglutide
Based on 1 publication(s) in Google Scholar
Dapiglutide (ZP7570) is a long-acting glucagon-like peptide-1 receptor 1R (GLP-1R)/Glucagon-like peptide-2 receptor (GLP-2R) dual agonist. Dapiglutide alleviates intestinal dysfunction in a mouse short bowel model and has anti-obesity effects.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity: 98.52%
- CAS No.: 2296814-85-0
- 화학식: C192H302N46O57
- 분자량:4166.79
-
보관:
Sealed storage, away from moisture and light, under nitrogen.
Powder -80°C, 2 years , -20°C, 1 year* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen)
Publications Citing Use of MedChemExpress (MCE) Dapiglutide
More
Biological Activity
제품 설명
In Vitro
Dapiglutide has an EC50 of 190 pM for GLP-1R and an EC50 of 210 pM for GLP-2R in HEK293 cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Dapiglutide (100 nmol/kg, once daily for four weeks) can reduce body weight in obese mice[3].
Pharmacokinetic Analysis in MC38 Syngeneic Model[2]
| Route | Dose (nmol/kg) | Animal | T1/2 (h) | Tmax (h) | F (%) |
| s.c. | 10 | Mice | 3.6 | 4.5 | 71 |
| s.c. | 10 | Rats | 7.7 | 9.0 | 58 |